HRP931065B1 - Avirulent antirabies vaccine - Google Patents

Avirulent antirabies vaccine

Info

Publication number
HRP931065B1
HRP931065B1 HR9208947A HRP931065A HRP931065B1 HR P931065 B1 HRP931065 B1 HR P931065B1 HR 9208947 A HR9208947 A HR 9208947A HR P931065 A HRP931065 A HR P931065A HR P931065 B1 HRP931065 B1 HR P931065B1
Authority
HR
Croatia
Prior art keywords
avirulent
antirabies
vaccine
antirabies vaccine
rabies
Prior art date
Application number
HR9208947A
Other languages
English (en)
Inventor
Florence Lafay
Original Assignee
Florence Lafay
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florence Lafay filed Critical Florence Lafay
Publication of HRP931065A2 publication Critical patent/HRP931065A2/hr
Publication of HRP931065B1 publication Critical patent/HRP931065B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/205Rhabdoviridae, e.g. rabies virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR9208947A 1992-07-20 1993-07-19 Avirulent antirabies vaccine HRP931065B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9208947A FR2693655B1 (fr) 1992-07-20 1992-07-20 Vaccin antirabique avirulent.

Publications (2)

Publication Number Publication Date
HRP931065A2 HRP931065A2 (en) 1995-02-28
HRP931065B1 true HRP931065B1 (en) 1999-12-31

Family

ID=9432070

Family Applications (1)

Application Number Title Priority Date Filing Date
HR9208947A HRP931065B1 (en) 1992-07-20 1993-07-19 Avirulent antirabies vaccine

Country Status (20)

Country Link
US (1) US5853735A (xx)
EP (1) EP0583998B1 (xx)
AT (1) ATE175877T1 (xx)
BG (1) BG61066B1 (xx)
BR (1) BR9302910A (xx)
CA (1) CA2100591C (xx)
CZ (1) CZ283400B6 (xx)
DE (1) DE69323130T2 (xx)
FI (1) FI933210A (xx)
FR (1) FR2693655B1 (xx)
HR (1) HRP931065B1 (xx)
HU (1) HU219266B (xx)
MA (1) MA22938A1 (xx)
MX (1) MX9304349A (xx)
PL (1) PL172853B1 (xx)
RO (1) RO112582B1 (xx)
RU (1) RU2128519C1 (xx)
SI (1) SI9300392A (xx)
SK (1) SK280104B6 (xx)
TN (1) TNSN93083A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL143149A0 (en) * 1998-11-27 2002-04-21 Akzo Nobel Nv Stable, attenuated rabies virus mutants and live vaccines thereof
PL352840A1 (en) 1999-06-03 2003-09-08 Nippon Suisan Kaisha, Ltd. Tricyclic fused heterocycle compounds, process for preparing the same and use thereof
US7074413B2 (en) 2000-03-23 2006-07-11 Thomas Jefferson University Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife
MXPA04000589A (es) 2001-07-20 2005-06-17 Univ Georgia Res Found Virus de la rabia atenuado con mutacion de nucleoproteina en el sitio de fosforilacion para vacunacion contra la rabia y terapia genetica en el snc.
ATE307606T1 (de) * 2001-10-04 2005-11-15 Ct Voor Onderzoek In Diergenee Abgeschwächter mutantenstamm eines virus der newcastle-krankheit für eine in ovo impfung und dessen benutzung
WO2003030933A1 (en) * 2001-10-10 2003-04-17 Thomas Jefferson University Recombinant rabies vaccine and methods of preparation and use
EP1415665A3 (en) * 2002-11-01 2004-06-30 ID-Lelystad, Instituut voor Dierhouderij en Diergezondheid B.V. BHV5 mutants
EP1768697B1 (en) 2004-07-12 2010-06-02 Thomas Jefferson University Recombinant rabies virus compositions
BRPI0617373B1 (pt) 2005-10-14 2022-04-05 The Goverment of The United States of America, Representado por, The Secretary of The Department of Health and Human Services, Centers for Disease Control and Prevention Composições e métodos do vírus da raiva
FR2944292B1 (fr) 2009-04-08 2013-08-23 Sanofi Pasteur Procede de purification du virus rabique
RU2694836C1 (ru) * 2018-12-14 2019-07-17 федеральное государственное бюджетное научное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБНУ "ФЦТРБ-ВНИВИ") Способ получения антигена вируса бешенства для серологической диагностики

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2580176B1 (fr) * 1985-04-12 1988-02-26 Centre Nat Rech Scient Vaccin antirabique avirulent
FR2633832B1 (fr) * 1988-07-05 1991-05-31 Virbac Vaccin antirabique avirulent

Also Published As

Publication number Publication date
EP0583998A1 (fr) 1994-02-23
RU2128519C1 (ru) 1999-04-10
CZ283400B6 (cs) 1998-04-15
ATE175877T1 (de) 1999-02-15
DE69323130T2 (de) 1999-06-17
US5853735A (en) 1998-12-29
MA22938A1 (fr) 1994-04-01
RO112582B1 (ro) 1997-11-28
HU9302091D0 (en) 1993-11-29
HUT69961A (en) 1995-09-28
CZ140293A3 (en) 1994-02-16
HU219266B (en) 2001-03-28
FI933210A0 (fi) 1993-07-14
TNSN93083A1 (fr) 1994-03-17
EP0583998B1 (fr) 1999-01-20
HRP931065A2 (en) 1995-02-28
BG97964A (bg) 1994-04-29
BG61066B1 (bg) 1996-10-31
SK280104B6 (sk) 1999-08-06
BR9302910A (pt) 1994-02-16
FR2693655B1 (fr) 1994-10-14
MX9304349A (es) 1994-06-30
CA2100591C (en) 2003-02-18
SI9300392A (en) 1994-06-30
CA2100591A1 (en) 1994-01-21
FR2693655A1 (fr) 1994-01-21
DE69323130D1 (de) 1999-03-04
FI933210A (fi) 1994-01-21
SK76193A3 (en) 1994-06-08
PL172853B1 (pl) 1997-12-31
PL299739A1 (en) 1994-01-24

Similar Documents

Publication Publication Date Title
ES2074950A1 (es) Vacuna para la prevencion de la enfermedad reproductiva y respiratoria de la cerda.
HRP931065B1 (en) Avirulent antirabies vaccine
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
GR3031698T3 (en) Vaccine against Streptococcus suis infection.
DK0425082T3 (da) Vacciner
RU93048174A (ru) Авирулентная вакцина против бешенства и способ ее получения
AU4334193A (en) Infectious bovine rhinotracheitis virus mutants and vaccines
CY2540B1 (en) Vaccine against mumps containing a jeryl-lynn virus strain
FR2633832B1 (fr) Vaccin antirabique avirulent
GR3034773T3 (en) Influenza vaccine containing pertussis toxin
YU50393A (sh) Nova vakcina protiv besnila
EP0668356A3 (en) Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20050719

Year of fee payment: 13

PBON Lapse due to non-payment of renewal fee

Effective date: 20060720